Review the side-effects of Thrombin Topical Bovine Origin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.
PARSIPPANY, NJ--(Marketwired - May 9, 2013) - The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin ...
February 5, 2010 — Results from 8 clinical trials show that recombinant human thrombin (rThrombin; Recothrom, ZymoGenetics, Inc) is well tolerated in several surgical settings for topical hemostasis ...
The FDA Thursday approved ZymoGenetics Inc.'s Recothrom Thrombin, the first and only recombinant, plasma-free thrombin for use as a topical hemostat. News of the approval sent shares of ZymoGenetics ...
17 Jan 2008 , Leverkusen : Bayer HealthCare announced today that its partner, ZymoGenetics Inc., received US Food and Drug Administration (FDA) approval of RECOTHROMâ„¢ Thrombin, topical (recombinant) ...
BRISTOL, Tenn. -- King Pharmaceuticals today reported that the U.S. Food and Drug Administration (FDA) has approved revised labeling for THROMBIN-JMI® (thrombin, topical, bovine, USP) as a result of ...
Additional Recothrom vial size approved The FDA has approved a 20000 IU vial size of Recothrom (recombinant topical thrombin, from ZymoGenetics) in addition to the 5000 IU vial already available. The ...
STAINES-UPON-THAMES, United Kingdom, March 19, 2018 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today it has closed the sale of RECOTHROM ® ...
Thrombin-JMI can cause fatal bleeding or thrombosis. Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results